WHO ICTRP trial
The secretome derived from mesenchymal stem cells for diabetic foot ulcer
IRCT20131009014957N16 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20131009014957N16 |
|---|---|
| Public title | The secretome derived from mesenchymal stem cells for diabetic foot ulcer |
| Scientific title | The efficacy and safety of secretome derived from human umbilical cord mesenchymal stem cells (HUCMSCs) for diabetic foot ulcer: A randomized controlled trial. |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Diabetic Foot Ulcer. Other specified diabetes mellitus |
| Interventions | Intervention 1: The first intervention group: recipients of secretome spray along with routine dressing, who will receive the allocated intervention for 8 weeks. The dressing will be changed once a week and the spray will be used every time… |
| Registration date | Oct 12, 2023 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: